Literature DB >> 12108533

Evaluation of quality improvement interventions to reduce inappropriate hospital use.

Michel P Kossovsky1, Pierre Chopard, Filippo Bolla, François P Sarasin, Martine Louis-Simonet, Anne-Françoise Allaz, Thomas V Perneger, Jean-Michel Gaspoz.   

Abstract

OBJECTIVE: To assess the impact of process analyses and modifications on inappropriate hospital use.
DESIGN: Pre-post comparison of inappropriate hospital use after process modifications.
SETTING: The Department of Internal Medicine of the Geneva University Hospitals, Switzerland. PARTICIPANTS: A random sample of 498 patients.
INTERVENTIONS: Two processes of care (i.e. non-urgent admissions and transfer to a rehabilitation hospital), which influenced inappropriate hospital use, were identified and modified. The impact of these modifications was then assessed. MAIN OUTCOME MEASURES: The proportion of inappropriate hospital admissions and inappropriate hospital days.
RESULTS: As a baseline assessment before quality improvement interventions, the appropriateness of hospital use (admissions and hospital days) was evaluated using the Appropriateness Evaluation Protocol (AEP) in a sample of 500 patients (5665 days). After modification of the two processes through a quality improvement program, inappropriate hospital use was reassessed in a sample of 498 patients (6095 days). Inappropriate hospital admissions decreased from 15 to 9% (P = 0.002) and inappropriate hospital days from 28 to 25% (P = 0.12).
CONCLUSION: Using the AEP as a criterion, the quality improvement interventions significantly reduced inappropriate hospital use due to the process of non-urgent admissions, but the reduction of inappropriate hospital days specifically attributed to the transfer to the rehabilitation hospital did not reach statistical significance.

Entities:  

Mesh:

Year:  2002        PMID: 12108533     DOI: 10.1093/oxfordjournals.intqhc.a002614

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  7 in total

1.  [Clinical pain consultation. Profiles of clinical pain consultation and requirements for management of complex pain patients in inpatient care].

Authors:  J Erlenwein; J Schlink; M Pfingsten; F Petzke
Journal:  Schmerz       Date:  2012-12       Impact factor: 1.107

2.  Developing of the appropriateness evaluation protocol for public hospitals in iran.

Authors:  Anvar Esmaili; Hamid Ravaghi; Hesam Seyedin; Bahram Delgoshaei; Masoud Salehi
Journal:  Iran Red Crescent Med J       Date:  2015-03-01       Impact factor: 0.611

3.  Predictors of inappropriate hospital stay: experience from Iran.

Authors:  Ali Asghar Ghods; Roghayeh Khabiri; Nayereh Raeisdana; Mehry Ansari; Nahid Hoshmand Motlagh; Malihe Sadeghi; Ehsan Zarei
Journal:  Glob J Health Sci       Date:  2014-11-17

4.  Investigating the Appropriateness of Admission and Hospitalization at a Teaching Hospital: A Case of a Developing Country.

Authors:  Mahmood Nekoei Moghadam; Mohammadreza Amiresmaili; Reza Goudarzi; Saeed Amini; Sajad Khosravi
Journal:  Iran J Public Health       Date:  2017-12       Impact factor: 1.429

5.  Direct costs associated with the appropriateness of hospital stay in elderly population.

Authors:  Joaquín F Mould-Quevedo; Carmen García-Peña; Iris Contreras-Hernández; Teresa Juárez-Cedillo; Claudia Espinel-Bermúdez; Gabriela Morales-Cisneros; Sergio Sánchez-García
Journal:  BMC Health Serv Res       Date:  2009-08-22       Impact factor: 2.655

6.  Reduction in inappropriate hospital use based on analysis of the causes.

Authors:  Víctor Soria-Aledo; Andrés Carrillo-Alcaraz; Benito Flores-Pastor; Alfredo Moreno-Egea; Milagros Carrasco-Prats; José Luis Aguayo-Albasini
Journal:  BMC Health Serv Res       Date:  2012-10-17       Impact factor: 2.655

7.  Reasons for discharge delays in teaching hospitals.

Authors:  Soraia Aparecida da Silva; Reginaldo Aparecido Valácio; Flávia Carvalho Botelho; Carlos Faria Santos Amaral
Journal:  Rev Saude Publica       Date:  2014-04       Impact factor: 2.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.